Analysis of Nosocomial Infection and Risk Factors in Patients with ECMO Treatment

References

• Wang GN, Chen XF, Qiao L, et al. Comparison of extracorporeal and conventional cardiopulmonary resuscitation: a meta-analysis of 2 260 patients with cardiac arrest. World J Emerg Med. 2017;8(1):5–11. doi:10.5847/wjem.j.1920-8642.2017.01.001.28123613
   PubMed Web of Science ®Google Scholar
• Brodie D, Bacchetta M. Extracorporeal membrane oxygenation for ards in adults. N Engl J Med. 2011;365(20):14–1905. doi:10.1056/NEJMct1103720
   Web of Science ®Google Scholar
• Hill JD, O’Brien TG, Murray JJ, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome: use of the Bramson membrane lung). N Engl J Med. 1972;286(12):629–634. doi:10.1056/NEJM197203232861204.5060491
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhuang J. Current situation and thinking of extracorporeal membrane oxygenation in China. Chin J Extracorporeal Circulation. 2017;15(02):68–71, 91.
   Google Scholar
• Dongzi X, Yangzhaolian O. Analysis on standardization of extracorporeal membrane oxygenation at home and abroa. China Med Devices. 2020;35(6):150–153.
   Google Scholar
• Firstenberg MS, Stahel PF, Hanna J, et al. Successful Covid-19 rescue therapy by extra-corporeal membrane oxygenation (ECMO) for respiratory failure: a case Report. Patient Saf Surg. 2020;14(4):20. doi:10.1186/s13037-020-00245-7.32395179
   PubMed Web of Science ®Google Scholar
• Gao G, Hei F, Ji B, et al. Retrospective analysis of related complications in 128 adult patients with the support treatment of external membrane oxygenation. Mol Cardiol China. 2015;15(1):1197–1201.
   Google Scholar
• Extracorporeal Life Support Organization (ELSO). ELSO ID task force recommendation summary. Ann Harbor, MI: ELSO; 2012: p. 8. Available from: https://www.elso.org/Portals/0/Files/ELSO-ID-Task-Force-Recommendations-Summary.pdf. Accessed 430, 2019.
   Google Scholar
• Alberto Z, Giovanni L, Giuseppe B, et al. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc. 2001;15(3):172–178.
   Google Scholar
• Zhou H, Li C, Wang X, et al. Distribution and drug resistance of pathogens causing nosocomial infections in patients with extracorporeal membrane oxygenation treatment. Chin J Nosocomiol. 2015;25(22):5097–5099.
   Google Scholar
• Li B, Sun G, Cheng Z, et al. Analysis of nosocomial infections in post-cardiac surgery extracorporeal membrane oxygenation support therapy. Heart Surg Forum. 2018;21(5):E387–E391. doi:10.1532/hsf.1789.30311890
   PubMed Web of Science ®Google Scholar
• Aditya S, Priya S, Stevens RW, et al. Reducing broad spectrum antimicrobial use in Extracorporeal Membrane Oxygenation (ECMO): reduce AMMO Study. Clin Infect Dis. 2021:ciab118. doi:10.1093/cid/ciab118..33575744
   PubMed Web of Science ®Google Scholar
• O’Horo JC, Cawcutt KA, De Moraes AG, Sampathkumar P, Schears GJ. The evidence base for prophylactic antibiotics in patients receiving extracorporeal membrane oxygenation. ASAIO J. 2016;62(1):6–10. doi:10.1097/MAT.0000000000000287.26461238
   PubMed Web of Science ®Google Scholar
• Hsu MS, Chiu KM, Huang YT, et al. Risk factors for nosocomial infection during extracorporeal membrane oxygenation. J Hosp Infect. 2009;73(3):210–216. doi:10.1016/j.jhin.2009.07.016.19782430
   PubMed Web of Science ®Google Scholar
• (CLSI) Clinical And Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Twenty Seven Informational Supplement. 27th ed. M100S; 2019.
   Google Scholar
• Bull T, Corley A, Smyth DJ, et al. Extracorporeal membrane oxygenation line-associated complications: in vitro testing of cyanoacrylate tissue adhesive and securement devices to prevent infection and dislodgement. Intensive Care Med Exp. 2018;6(1):6. doi:10.1186/s40635-018-0171-8.29532189
   PubMed Web of Science ®Google Scholar
• Zhou N, Bao M, Wang Z. Research progress of extracorporeal membrane oxygenation support therapy and prevention of complications. Clin Misdiagn Misther. 2018;31(4):106–111.
   Google Scholar
• Wang J, Xiong Y, Shi Y, et al. Risk factors and etiology of nosocomial infection associated with extracorporeal membrane oxygenation in adult patients with cardiac problems after extracorporeal membrane oxygenation. Chin J Clin Infect Dis. 2019;38–43.
   Google Scholar
• Sun G, Li B, Ye Z, et al. Risk factors of infection in patients receiving extracorporeal membrane oxygenation support therapy. Chin J Thorac Surg. 2016;3(4):209–215.
   Google Scholar
• Zeng W, Xiao G, Zhong Z, et al. Risk factors of nosocomial infection after extracorporeal membrane oxygenation. Chin J Infect Control. 2014;13(4):212–214.
   Google Scholar
• Xiaozu L, Binfei L, Geqin S, et al. Analysis of nosocomial infection after extracorporeal membrane oxygenation supportive treatment after cardiac surgery. South China J Cardiovasc Dis. 2018;24(2):165–168.
   Google Scholar
• Bizzarro MJ, Conrad SA, Kaufman DA, et al. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med. 2011;12(3):277. doi:10.1097/PCC.0b013e3181e28894.20495508
   PubMed Web of Science ®Google Scholar
• Wu G, Zhang G, Chen L, et al. Distribution and drug sensitivity of multi-drug-resistant bacteria in key departments of a hospital from 2016 to 2017. Clin J Med Officer. 2019;47(9):970–971, 974.
   Google Scholar
• Committee of Expert on Rational Drug Use of National Health Commission of the P.R. China, Ministry of Health National Antimicrobial Resistance Investigation Net. China antimicrobial resistance surveillance system in 2018. China Licensed Pharmacist. 2020;017(1):1–10.
   Google Scholar
• Amaya-Villar R, Garnacho-Montero J. How should we treat Acinetobacter pneumonia? Curr Opin Crit Care. 2019;25(5):465–472. doi:10.1097/MCC.0000000000000649.31335380
   PubMed Web of Science ®Google Scholar
• El-Lababidi RM, Rizk JG. Cefiderocol: a Siderophore Cephalosporin. Ann Pharmacother. 2020;54(12):1215–1231. doi:10.1177/1060028020929988.32522005
   PubMed Web of Science ®Google Scholar
• Zhu H, Yao J, Dong T, et al. Nosocomial infection and drug resistance of Klebsiella pneumoniae from 2011 to 2013. Chin J Health Lab Technol. 2015;586–589.
   Google Scholar
• Gaiarsa S, Comandatore F, Gaibani P, et al. Genomic epidemiology of Klebsiella pneumoniae in Italy and novel insights into the origin and global evolution of its resistance to carbapenem antibiotics. Antimicrob Agents Chemother. 2015;59(1):389–396. doi:10.1128/AAC.04224-1425367909
   PubMed Web of Science ®Google Scholar
• Juthani BK, Macfarlan J, Wu J, Misselbeck TS. Incidence of nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation. Heart Lung. 2018;47(6):626–630. doi:10.1016/j.hrtlng.2018.07.004.30166066
   PubMed Web of Science ®Google Scholar
• Tan Y, Wang Y, Cai S, et al. Epidemiological characteristics of nosocomial infection in adult patients undergoing extracorporeal membrane oxygenation. Chin J Nosocomiol. 2020;30(22):3434–3438.
   Google Scholar
• Donker DW, Brodie D, Henriques JPS, Broomé M. Left ventricular unloading during veno-arterial ECMO: a review of percutaneous and surgical unloading interventions. Sage Choice. 2019;34(2). doi:10.1177/0267659118794112.
   Google Scholar
• Wang J, Huang J, Hu W, et al. Risk factors and prognosis of nosocomial pneumonia in patients undergoing extracorporeal me mbrane oxygenation: a retrospective study. J Int Med Res. 2020;48:300060520964701. doi:10.1177/0300060520964701.33086927
   PubMed Web of Science ®Google Scholar